Factors reducing omalizumab response in severe asthma.

CONCLUSION: Age, obesity, comorbidities, smoking habits, nasal polyps, allergic poly-sensitization might reduce Omalizumab effectiveness independently to other asthma-influencing factors.
PMID: 29395935 [PubMed - as supplied by publisher]

Source: European Journal of Internal Medicine - January 29, 2018 Category: Internal Medicine Authors: Sposato B, Scalese M, Milanese M, Masieri S, Cavaliere C, Latorre M, Scichilone N, Matucci A, Vultaggio A, Ricci A, Cresti A, Santus P, Perrella A, Paggiaro PL Tags: Eur J Intern Med Source Type: research